Skip to main content
Clinical Trials/NCT06922734
NCT06922734Active, not recruitingNot Applicable

Post-stroke Seizures and EEG Analysis

University Medical Centre Maribor1 site in 1 country602 target enrollmentStarted: November 1, 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
602
Locations
1
Primary Endpoint
post-stroke EEG characteristics

Study Overview

Brief Summary

This research aims to determine the frequency of seizures in patients following a stroke, identify risk factors associated with post-stroke seizures, and characterize EEG changes linked to these seizures. Unexplored alterations in the aperiodic component of the EEG in post-stroke patients could potentially serve as novel biological markers for epilepsy after stroke.

Detailed Description

This study included patients with stroke or post-stroke seizures who were admitted to the Neurology Division at the University Medical Centre Maribor, Slovenia, over a 12-month period. The anticipated number of patients was approximately 600-650. Inclusion criteria encompassed acute stroke or seizure occurring at any point after the stroke. Stroke classification was based on the World Health Organization (WHO) criteria, while post-stroke seizures and epilepsy were defined according to the International League Against Epilepsy (ILAE) definitions and classifications.

All participants provided written informed consent after being thoroughly informed about the study. The study was pre-approved by the Medical Ethics Committee of the Republic of Slovenia (Approval No. 48/08/14 and Approval No. 0120-302/2024-2711-3). Patients who did not meet the inclusion criteria or could not undergo diagnostic procedures as outlined in the research protocol were excluded based on principles of good clinical practice.

During the 12-month study period, demographic, imaging, laboratory, and neurophysiological data were prospectively collected from all hospitalized stroke patients.

Data Collection

Patient history was utilized to gather information on neurological impairments, seizure onset, and risk factors for cerebrovascular diseases. For patients who experienced seizures, the interval between stroke onset and seizure occurrence (in days) was calculated to distinguish early from late post-stroke seizures.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Patients were eligible for inclusion if they had experienced an acute stroke or a seizure occurring at any point after a previous stroke.

Exclusion Criteria

  • •Patients were excluded from the study if they did not meet the inclusion criteria or if diagnostic procedures could not be performed in accordance with the research protocol. Exclusions were made following good clinical practice principles.

Arms & Interventions

EEG+/EPI- group

Patients with epileptiform EEG changes but no seizures

EEG-/EPI-group

Patients without epileptiform EEG changes and no seizures

KON group

A control group of comparable healthy individuals

EEG+/EPI+ group

Patients with epileptiform EEG changes and seizures

Outcomes

Primary Outcomes

post-stroke EEG characteristics

Time Frame: From enrollment of first patient to the last one in 12 months

Investigators are interested in specific EEG changes which may indicate risk factors for post-stroke seizures

Post-stroke seizure prevalence

Time Frame: From enrollment of first patient to the last one in 12 months

Risk factors of post-stroke seizures

Time Frame: From enrollment of first patient to the last one in 12 months

Investigators are interested in serum and radiological biomarkers as risk factors for post-stroke seizures

Secondary Outcomes

  • Aperiodic EEG component in patients after stroke with and without seizures(From enrollment to the end of hospitalisation)

Investigators

Sponsor
University Medical Centre Maribor
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Albin Gačnik MD

MD, Senior Consultant Neurologist

University Medical Centre Maribor

Study Sites (1)

Loading locations...

Similar Trials